O-66 Impact of whole brain radiation therapy (WBRT) and motexafin gadolinium (MGd) on neurologic and neurocognitive progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a randomized phase III trial Article

Mehta, Minesh P, Bezjak, Andrea, Suh, John et al. (2003). O-66 Impact of whole brain radiation therapy (WBRT) and motexafin gadolinium (MGd) on neurologic and neurocognitive progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a randomized phase III trial . 41 s22. 10.1016/s0169-5002(03)91724-7

cited authors

  • Mehta, Minesh P; Bezjak, Andrea; Suh, John; Rodrigus, Patrick TR; Sagar, Stephen; Kunkler, Ian H; Carrie, Christian; Smith, Jennifer A; Renschler, Markus F; Phan, See-Chun

authors

publication date

  • August 1, 2003

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6.1 Pharmaceuticals
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Lung
  • Lung Cancer
  • Neurosciences
  • Radiation Oncology
  • Women's Health

Digital Object Identifier (DOI)

publisher

  • Elsevier

start page

  • s22

volume

  • 41